LIGAND PHARMACEUTICALS INCORPORATED
EPS
| Period | EPS |
|---|---|
| Mar 2017 | $1.83 |
| Jun 2017 | $2.99 |
| Sep 2017 | $2.80 |
| Dec 2017 | $-2.02 |
| Mar 2018 | $1.83 |
| Jun 2018 | $2.99 |
| Sep 2018 | $2.80 |
| Dec 2018 | $-2.02 |
| Mar 2019 | $31.32 |
| Jun 2019 | $-0.74 |
| Sep 2019 | $-0.81 |
| Dec 2019 | $-0.43 |
| Mar 2020 | $-1.46 |
| Jun 2020 | $1.32 |
| Sep 2020 | $-0.42 |
| Dec 2020 | $0.35 |
| Mar 2021 | $1.05 |
| Jun 2021 | $1.79 |
| Sep 2021 | $0.80 |
| Dec 2021 | $-0.19 |
| Mar 2022 | $-0.91 |
| Jun 2022 | $-0.05 |
| Sep 2022 | $0.02 |
| Dec 2022 | $-0.86 |
| Mar 2023 | $2.33 |
| Jun 2023 | $0.13 |
| Sep 2023 | $-0.59 |
| Mar 2024 | $4.75 |
| Jun 2024 | $-2.88 |
| Sep 2024 | $-0.39 |
| Mar 2025 | $-2.21 |
| Jun 2025 | $0.24 |
| Sep 2025 | $5.68 |
| Mar 2026 | $-0.67 |
| Jun 2026 | $2.22 |